| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/24/2005 | WO2005026359A2 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | WO2005026358A1 Polymorphisms in selenoprotein s |
| 03/24/2005 | WO2005026345A1 Plant dwarfing gene |
| 03/24/2005 | WO2005026342A1 Methods of modulating bone growth, bone remodeling and adiposity |
| 03/24/2005 | WO2005026337A2 Adenoviral vector for infecting cells deficient in a car receptor |
| 03/24/2005 | WO2005026317A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 |
| 03/24/2005 | WO2005026316A2 Alphavirus vaccines |
| 03/24/2005 | WO2005026315A2 Method for producing insulin from a natural source and insulin |
| 03/24/2005 | WO2005026211A2 Anti-ghrelin antibodies |
| 03/24/2005 | WO2005026209A2 Monoclonal antibodies against hmgb1 |
| 03/24/2005 | WO2005026208A2 Chimeric gabab receptor |
| 03/24/2005 | WO2005026207A2 Adipocyte complement related protein zacrp12 |
| 03/24/2005 | WO2005026206A2 Vegf-induced genes and their therapeutic use |
| 03/24/2005 | WO2005026205A2 Genetic products which are differentially expressed in tumours and use thereof |
| 03/24/2005 | WO2005026204A2 Synthetic antimicrobial polypeptides |
| 03/24/2005 | WO2005026203A2 Dna promoters and anthrax vaccines |
| 03/24/2005 | WO2005026202A1 Compositions comprising a fragment of the herpesviral protein vp22 for delivery of substances to cells |
| 03/24/2005 | WO2005026201A1 Immortalisation of mammalian cells and therapeutic applications of said cells |
| 03/24/2005 | WO2005026200A2 Lawsonia intracellularis subunit vaccine |
| 03/24/2005 | WO2005026199A2 Piroplasmid vaccine |
| 03/24/2005 | WO2005026195A1 Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive aspergillosis |
| 03/24/2005 | WO2005026194A2 Granulysin peptides and methods of use thereof |
| 03/24/2005 | WO2005026192A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005025624A2 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 03/24/2005 | WO2005025612A1 Vaccines |
| 03/24/2005 | WO2005025607A1 Methods of stimulating innate immunity using cationic peptides |
| 03/24/2005 | WO2005025606A1 Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 03/24/2005 | WO2005025603A2 Methods of using wisp antagonists |
| 03/24/2005 | WO2005025601A1 Follistatin isoforms and uses thereof |
| 03/24/2005 | WO2005025600A1 Drug inhibiting mobilization of adhesive cells into peripheral blood |
| 03/24/2005 | WO2005025597A1 Peptides that promote complement activation |
| 03/24/2005 | WO2005025592A2 In vivo modulation of neuronal transport |
| 03/24/2005 | WO2005025590A2 Use of a dg280 protein product for preventing and treating metabolic disorders |
| 03/24/2005 | WO2005025517A2 Animal model for protease activity and liver damage |
| 03/24/2005 | WO2005025497A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005025312A2 Insecticidal compounds and methods for selection thereof |
| 03/24/2005 | WO2005025310A2 MODEL SYSTEM FOR TCR ξ CHAIN DOWNREGULATION |
| 03/24/2005 | WO2005016963A3 Heparin binding veger-3 ligands |
| 03/24/2005 | WO2005012355B1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 03/24/2005 | WO2005012349A3 Chromatographic process for the purification of notch ligands |
| 03/24/2005 | WO2005007824A3 Mutants of vaccinia virus as oncolytic agents |
| 03/24/2005 | WO2005006846A3 Generation of plants with altered oil content |
| 03/24/2005 | WO2005006845A3 Generation of plants with altered oil content |
| 03/24/2005 | WO2005005477A3 Stabilised insulin compositions |
| 03/24/2005 | WO2005005464A3 Peptide-based linker |
| 03/24/2005 | WO2005003297A3 Mptens as modifiers of the pten/igf pathway and methods of use |
| 03/24/2005 | WO2005000886A3 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 03/24/2005 | WO2005000336A3 The use of caldag-gefi inhibitors as antithrombotic agents |
| 03/24/2005 | WO2004112831A3 High titer recombinant influenza viruses for vaccines and gene therapy |
| 03/24/2005 | WO2004111194A3 Method to increase protein production in culture |
| 03/24/2005 | WO2004111074A9 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/24/2005 | WO2004108079A3 Parkin-interacting proteins |
| 03/24/2005 | WO2004105681A3 Cd4+ human papillomavirus (hpv) epitopes |
| 03/24/2005 | WO2004103400A3 Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines |
| 03/24/2005 | WO2004101766A3 Grp94-based compositions and methods of use thereof |
| 03/24/2005 | WO2004100985A3 Materials and methods for immunizing against fiv infection |
| 03/24/2005 | WO2004099386A9 Gene silencing by systemic rna interference |
| 03/24/2005 | WO2004099240A3 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars) |
| 03/24/2005 | WO2004096854A3 Insulin analogs having protracted time action |
| 03/24/2005 | WO2004094468A3 Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections |
| 03/24/2005 | WO2004093528A3 Generation of plants with altered oil content |
| 03/24/2005 | WO2004092738A3 Assay for modulators of e2f-1 phosphorylation |
| 03/24/2005 | WO2004092337A3 Promoting cardiac cell differentiation |
| 03/24/2005 | WO2004091438A3 Improved ophthalmic and contact lens solutions containing peptides as representative enhancers |
| 03/24/2005 | WO2004087952A3 Genes regulated by hydrogen peroxide stress |
| 03/24/2005 | WO2004085466A3 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 03/24/2005 | WO2004083385A3 Quorum sensing signaling in bacteria |
| 03/24/2005 | WO2004074318A3 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 03/24/2005 | WO2004071387A3 Hsp60 from arthrobacter |
| 03/24/2005 | WO2004069867A3 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 03/24/2005 | WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen |
| 03/24/2005 | WO2004063212A3 Organic compounds with biological action as thrombin inhibitors and use therof |
| 03/24/2005 | WO2004060925A3 Multiplex polymer ligation |
| 03/24/2005 | WO2004058165A3 Saposing c and receptors as targets for treatment of benign and malignant disorders |
| 03/24/2005 | WO2004052933A3 Peptide oligomers for use as hiv vaccines |
| 03/24/2005 | WO2004050856A3 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
| 03/24/2005 | WO2004048547A3 Intermedin and its uses |
| 03/24/2005 | WO2004046336A8 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 03/24/2005 | WO2004044162A3 HUMAN ACID-SENSING ION CHANNEL 2b (hASIC2b) |
| 03/24/2005 | WO2004031347A3 Methods and compositions for soluble cpg15 |
| 03/24/2005 | WO2004024777A8 Hydroxyalkyl starch derivatives |
| 03/24/2005 | WO2004020591A3 Methods of use for novel human polypeptides encoded by polynucleotides |
| 03/24/2005 | WO2004016228A3 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS |
| 03/24/2005 | WO2004014955A9 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 03/24/2005 | WO2004013293A3 Transporters and ion channels |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2003090687A9 Using heat shock proteins to increase immune response |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003080667A3 A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 03/24/2005 | WO2003060151A3 Novel calpastatin (cast) alleles |
| 03/24/2005 | WO2003045973A8 Peptides with growth inhibitory action |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | WO2002058450A3 Regulation of cell growth by muc1 |
| 03/24/2005 | WO2001068858A8 Human g protein-coupled receptors |
| 03/24/2005 | WO2000078801A9 Insulin-like growth factor agonist molecules |
| 03/24/2005 | US20050066396 Casein kinase stress-related polypeptides and methods of use in plants |
| 03/24/2005 | US20050066395 Methods for modification of plant inflorescence architecture |
| 03/24/2005 | US20050066394 Expression vector comprising nucleotide sequences coding flowering locus t (FT) for use as tool in generating plants wijth enhanced shoot and flower development |
| 03/24/2005 | US20050066392 Expression vector comprising nucleotide sequences coding which confer a tolerant phenotype in plants in response to chronic and/or acute inhibitin dosages of auxinic herbicides |